We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Revvity AlphaLISA. SureFire Ultra. Human Phospho-TIE2 Tyr992 Detection Kit, 100 Assay Points
The TEK receptor tyrosine kinase (TIE2), encoded by the TEK gene in humans, is primarily expressed on endothelial cells. Upon binding with angiopoietin-1 (Angpt1), TIE2 induces angiogenesis and supports endothelial cell survival. This activation leads to downstream signaling pathways, including MEK/ERK, IKKb/NFkB, and AKT. Consequently, TIE2 contributes to vascular stability, cellular proliferation, inflammation, and cell survival. Elevated levels of Ang1 and/or Ang2 have been observed in patients with various cancers.
The AlphaLISA SureFire Ultra Human Phospho-TIE2 (Tyr992) Detection Kit is a sandwich immunoassay for the quantitative detection of phospho-TIE2 in cellular lysates, using Alpha technology.
Formats:
- The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
- The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
- The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
- The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.
AlphaLISA SureFire Ultra kits are compatible with:
- Cell and tissue lysates
- Antibody modulators
- Biotherapeutic antibodies
Alpha SureFire kits can be used for:
- Cellular kinase assays
- Receptor activation studies
- High-throughput drug screening
| SKU | PEMSD-ALSU-PTIE2-A-HV |
|---|---|
| Featured | No |
| Supplier Part Number | ALSU-PTIE2-A-HV |
| UM | EA |
| UNSPSC | 41116126 |
| Manufacturer | Revvity |
| CountryOfOrigin | Australia |
| ProductLine | PEMSD |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 0.500000 |
| Lead Time | 4 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| ACT Ecolabel | No |
| Controlled | N |